Annual Reports
IR Home | SEC Filings | Annual Reports | Company News
Mgmt & Board | Code of Ethics | Webcast
IR Home | SEC Filings | Annual Reports | Company News
Mgmt & Board | Code of Ethics | Webcast
08/06/10 - Lannett Receives FDA Approval For Ondansetron Injection, USP 2 MG/ML Single-Dose Vials...more
08/05/10 - Lannett To Present At Bank Of America/Merrill Lynch 2010 Pharmaceuticals Conference...more
07/20/10 - Lannett Receives FDA Approval For Phentermine Hydrochloride Capsules USP 30 MG...more
06/02/10 - Lannett To Present at Jefferies 2010 Global Life Sciences Conference...more
05/12/10 - Lannett Company, Inc. And Subsidiaries Consolidated Statements Of Operations (Unaudited)...more